Skip to content
Capsule Allopathic

BetriXa 80 mg capsule

Generic: Betrixaban

Company: Square Pharmaceuticals PLC. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength80 mg
PackBox of 10: 1150.00 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated March 23, 2025.

Compare

Same generic, same strength

Sorted by price per capsule. Ask your pharmacist before you switch brands.

Betrixaban 80 mg capsules

Prices as listed on BestinMeds.

1 brand listed
BetriXa, box of 10 (this medicine)115.00 taka per capsule

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Betrixaban guide

Indications

Venous thromboembolism Betrixaban is indicated for the prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness and at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE.

Dosage and administration

The recommended dose of Betrixaban is an initial single dose of 160 mg, followed by 80 mg once daily. Daily oral doses should be given at the same time of day with food. The recommended duration of treatment is 35 to 42 days.

Side effects

Most common adverse reaction is bleeding, epidural or spinal hematoma may develop during spinal/epidural anesthesia or puncture.

Precautions and warnings

Risk of Bleeding: Can cause bleeding. Promptly evaluate any signs or symptoms of blood loss. Spinal/Epidural Anesthesia or Puncture: When neuraxial anesthesia (spinal/epidural anesthesia) or spinal/epidural puncture is employed, patients treated with antithrombotic agents for prevention of thromboembolic complications are at risk of developing an epidural or spinal hematoma which can result in long-term or permanent paralysis. Do not remove an epidural catheter earlier than 72 hours after the last administration of Betrixaban. Do not administer the next Betrixaban dose earlier than 5 hours after the removal of the catheter. If traumatic puncture occurs, delay the administration of Betrixaban for 72 hours. Severe Renal Impairment: Increase risk of bleeding events. Concomitant P-gp Inhibitors: Increase risk of bleeding events.

Pregnancy and lactation

Use in Pregnancy: There are no data with the use of Betrixaban in pregnant women, but treatment is likely to increase the risk of hemorrhage during pregnancy and delivery. Lactation: No data are available regarding the presence of Betrixaban or its metabolites in human milk, the effects of the drug on the breastfed infant, or the effects of the drug on milk production.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250